 | Up a level |
Koehler, N., Jordan, K., Jahn, F., Woermann, B. and Skoetz, N. (2016). Bisphosphonates or RANK-ligand inhibitors for patients with solid cancer and bone metastases or multiple myeloma: a systematic Cochrane review and meta-analysis. Oncol. Res. Treat., 39. S. 164 - 165. BASEL: KARGER. ISSN 2296-5262
Macherey, S., Jahn, F., Jordan, K. and Skoetz, N. (2016). Bisphosphonates for patients with bone metastases from prostate cancer. A Cochrane review update including more than 5,000 patients. Oncol. Res. Treat., 39. S. 22 - 24. BASEL: KARGER. ISSN 2296-5262
Skoetz, N., Haque, M., Monsef, I, Jordan, K., Kuhr, K. and Scheckel, B. (2018). Antiemetics for highly emetogenic chemotherapy: A systematic review and network meta-analysis. Oncol. Res. Treat., 41. S. 212 - 214. BASEL: KARGER. ISSN 2296-5262